Literature DB >> 22492934

Early apoptosis in different models of cardiac hypertrophy induced by high renin-angiotensin system activity involves CaMKII.

J Omar Velez Rueda1, Julieta Palomeque, Alicia Mattiazzi.   

Abstract

The objective of this study was to establish whether 1) hyperactivity of renin-angiotensin-aldosterone system (RAAS) produces apoptosis in early stages of cardiac disease; and 2) Ca(2+)-calmodulin-dependent protein kinase II (CaMKII) is involved in these apoptotic events. Two models of hypertrophy were used at an early stage of cardiac disease: spontaneously hypertensive rats (SHR) and isoproterenol-treated rats (Iso-rats). At 4 mo, SHR showed blood pressure, aldosterone serum levels, used as RAAS activity index, and left ventricular mass index, used as hypertrophy index, above control values by 84.2 ± 2.6 mmHg, 211.2 ± 25.8%, and 8.6 ± 1.1 mg/mm, respectively. There was also an increase in apoptotis (Bax-to-Bcl-2 ratio and terminal deoxynucleotidyl transferase dUTP-mediated nick-end labeling positive cells) associated with an enhancement of CaMKII activity with respect to age-matched controls (phosphorylated-CaMKII, 98.7 ± 14.1 above control). Similar results were observed in 4-mo-old Iso-rats. Cardiac function studied by echocardiography remained unaltered in all groups. Enalapril treatment significantly prevented hypertrophy, apoptosis, and CaMKII activity. Moreover, intracellular Ca(2+) handling in isolated myocytes was similar between SHR, Iso-rats, and their aged-matched controls. However, SHR and Iso-rats showed a significant increase in superoxide anion generation (lucigenin) and lipid peroxidation (thiobarbituric acid reactive substance). In transgenic mice with targeted cardiomyocyte expression of a CaMKII inhibitory peptide (AC3-I) or a scrambled control peptide (AC3-C), Iso treatment increased thiobarbituric acid reactive substance in both strains, whereas it increased CaMKII activity and apoptosis only in AC3-C mice. Endogenous increases in RAAS activity induce ROS and CaMKII-dependent apoptosis in vivo. CaMKII activation could not be associated with intracellular Ca(2+) increments and was directly related to the increase in oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492934      PMCID: PMC3774203          DOI: 10.1152/japplphysiol.01383.2011

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  47 in total

Review 1.  Measurement of reactive oxygen species in cardiovascular studies.

Authors:  Sergey Dikalov; Kathy K Griendling; David G Harrison
Journal:  Hypertension       Date:  2007-02-12       Impact factor: 10.190

2.  CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury.

Authors:  Martin Vila-Petroff; Margarita A Salas; Matilde Said; Carlos A Valverde; Luciana Sapia; Enrique Portiansky; Roger J Hajjar; Evangelia G Kranias; Cecilia Mundiña-Weilenmann; Alicia Mattiazzi
Journal:  Cardiovasc Res       Date:  2006-12-15       Impact factor: 10.787

Review 3.  CaMKII in the cardiovascular system: sensing redox states.

Authors:  Jeffrey R Erickson; B Julie He; Isabella M Grumbach; Mark E Anderson
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

4.  BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M.

Authors:  K Yamamoto; H Ichijo; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

5.  Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK.

Authors:  Julieta Palomeque; Luciana Sapia; Roger J Hajjar; Alicia Mattiazzi; Martín Vila Petroff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-29       Impact factor: 4.733

6.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

7.  Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system.

Authors:  D Grimm; D Elsner; H Schunkert; M Pfeifer; D Griese; G Bruckschlegel; F Muders; G A Riegger; E P Kromer
Journal:  Cardiovasc Res       Date:  1998-01       Impact factor: 10.787

8.  PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis.

Authors:  Yi-He Ling; Leonard Liebes; Bruce Ng; Michael Buckley; Peter J Elliott; Julian Adams; Jian-Dong Jiang; Franco M Muggia; Roman Perez-Soler
Journal:  Mol Cancer Ther       Date:  2002-08       Impact factor: 6.261

9.  The signalling pathway of CaMKII-mediated apoptosis and necrosis in the ischemia/reperfusion injury.

Authors:  Margarita A Salas; Carlos A Valverde; Gina Sánchez; Matilde Said; Jesica S Rodriguez; Enrique L Portiansky; Marcia A Kaetzel; John R Dedman; Paulina Donoso; Evangelia G Kranias; Alicia Mattiazzi
Journal:  J Mol Cell Cardiol       Date:  2010-01-06       Impact factor: 5.000

10.  Redox regulation of the calcium/calmodulin-dependent protein kinases.

Authors:  Christopher J Howe; Michelle M Lahair; James A McCubrey; Richard A Franklin
Journal:  J Biol Chem       Date:  2004-08-04       Impact factor: 5.157

View more
  22 in total

1.  Oxidative activation of the Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) regulates vascular smooth muscle migration and apoptosis.

Authors:  Linda J Zhu; Paula J Klutho; Jason A Scott; Litao Xie; Elizabeth D Luczak; Megan E Dibbern; Anand M Prasad; Omar A Jaffer; Ashlee N Venema; Emily K Nguyen; Xiaoqun Guan; Mark E Anderson; Isabella M Grumbach
Journal:  Vascul Pharmacol       Date:  2014-01-10       Impact factor: 5.773

Review 2.  Chasing cardiac physiology and pathology down the CaMKII cascade.

Authors:  Alicia Mattiazzi; Rosana A Bassani; Ariel L Escobar; Julieta Palomeque; Carlos A Valverde; Martín Vila Petroff; Donald M Bers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-06       Impact factor: 4.733

3.  Calcium-calmodulin-dependent protein kinase mediates the intracellular signalling pathways of cardiac apoptosis in mice with impaired glucose tolerance.

Authors:  Marilen Federico; Enrique L Portiansky; Leandro Sommese; Francisco J Alvarado; Paula G Blanco; Carolina N Zanuzzi; John Dedman; Marcia Kaetzel; Xander H T Wehrens; Alicia Mattiazzi; Julieta Palomeque
Journal:  J Physiol       Date:  2017-03-02       Impact factor: 5.182

4.  Posttranslational modifications of calcium/calmodulin-dependent protein kinase IIδ and its downstream signaling in human failing hearts.

Authors:  Tomas Rajtik; Eva Goncalvesova; Zoltan V Varga; Przemyslaw Leszek; Mariusz Kusmierczyk; Michal Hulman; Jan Kyselovic; Peter Ferdinandy; Adriana Adameova
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

5.  Oxidative activation of Ca(2+)/calmodulin-activated kinase II mediates ER stress-induced cardiac dysfunction and apoptosis.

Authors:  Nathan D Roe; Jun Ren
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-11       Impact factor: 4.733

6.  Reversible redox modifications of ryanodine receptor ameliorate ventricular arrhythmias in the ischemic-reperfused heart.

Authors:  Romina Becerra; Bárbara Román; Mariano N Di Carlo; Juan Ignacio Mariangelo; Margarita Salas; Gina Sanchez; Paulina Donoso; Guillermo R Schinella; Leticia Vittone; Xander H Wehrens; Cecilia Mundiña-Weilenmann; Matilde Said
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-15       Impact factor: 4.733

Review 7.  Regulation of CaMKII signaling in cardiovascular disease.

Authors:  Mariya Y Mollova; Hugo A Katus; Johannes Backs
Journal:  Front Pharmacol       Date:  2015-08-25       Impact factor: 5.810

Review 8.  Mechanisms of CaMKII Activation in the Heart.

Authors:  Jeffrey R Erickson
Journal:  Front Pharmacol       Date:  2014-04-02       Impact factor: 5.810

9.  Effect of renal sympathetic denervation on atrial substrate remodeling in ambulatory canines with prolonged atrial pacing.

Authors:  Xule Wang; Qingyan Zhao; He Huang; Yanhong Tang; Jinping Xiao; Zixuan Dai; Shengbo Yu; Congxin Huang
Journal:  PLoS One       Date:  2013-05-27       Impact factor: 3.240

10.  Similar to spironolactone, oxymatrine is protective in aldosterone-induced cardiomyocyte injury via inhibition of calpain and apoptosis-inducing factor signaling.

Authors:  Ting-Ting Xiao; Yuan-Yuan Wang; Yan Zhang; Cong-Hui Bai; Xiang-Chun Shen
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.